Forte Biosciences (FBRX) Misses Q2 EPS by 4c

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue